Telmisartan showed no evidence of mutagenicity and relevant clastogenic activity in in vitro studies and no evidence of carcinogenicity in rats and mice.
Tyrimų in vitro metu mutageninio ar reikšmingo klastogeninio telmisartano poveikio nepastebėta.